Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00491608 · ClinicalTrials.gov registry record · Phase 3
Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis
A Phase 3 study, sponsored by ZymoGenetics.
- Completed
- Registry status
- Phase 3
- Development phase
- 234
- Enrollment target
NCT00491608 is a Phase 3 study that has completed, run by ZymoGenetics. The registered enrollment target is 234 participants.
The verdict
NCT00491608, a Phase 3 study, has completed, sponsored by ZymoGenetics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 234 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and immune system response to recombinant thrombin when used to control bleeding in spinal and vascular surgery.
Interventions
- BIOLOGICAL rThrombin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00491608
The ClinicalTrials.gov registry entry for NCT00491608 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZymoGenetics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which rThrombin is the first listed.
NCT00491608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00491608 about?
NCT00491608 is a clinical study titled "Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis". The purpose of this study is to evaluate the safety and immune system response to recombinant thrombin when used to control bleeding in spinal and vascular surgery.
What is the current status of trial NCT00491608?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 234 participants. The study started on 2007-06. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00491608?
The interventions under investigation include: rThrombin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00491608?
This trial is sponsored by ZymoGenetics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.